Treating Advanced Sarcoma: One Size Does Not Fit All
1 Tampilan
• 07/18/23
0
0
Menanamkan
administrator
Pelanggan
Dr. Nikhil Khushalani, Section Chief of Soft Tissue and Melanoma & Director of the IL-2 Program, Department of Medicine, RPCI, gives an overview of the treatment strategies used in advanced soft tissue sarcoma, including a new drug, approved by the FDA in April 2012, called pazopanib.
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru